Company / Shareholders' Equity
BIODESIX INC Shareholders' Equity History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
-$2.5M
FY2025
5-year range
-$2.5M / $20.9M
FY2021-FY2025
Trend
-111.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
BIODESIX INC reports negative total equity of -$2M in FY2025. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-$2M in FY2025.
Declined from $5M to -$2M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, shareholders' equity decreased 111.8% year-over-year.
- Peak shareholders' equity was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -4.69 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.5M | -111.8% |
| FY2024 | $20.9M | +355.8% |
| FY2023 | $4.6M | -77.8% |
| FY2022 | $20.6M | +4.5% |
| FY2021 | $19.7M | -52.1% |
| FY2020 | $41.2M | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026